Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma.

Saved in:
Bibliographic Details
Title: Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma.
Authors: Owen, C.N.1,2 (AUTHOR), Bai, X.3,4 (AUTHOR), Quah, T.5 (AUTHOR), Lo, S.N.1 (AUTHOR), Allayous, C.6 (AUTHOR), Callaghan, S.7 (AUTHOR), Martínez-Vila, C.8 (AUTHOR), Wallace, R.9 (AUTHOR), Bhave, P.10 (AUTHOR), Reijers, I.L.M.11 (AUTHOR), Thompson, N.2 (AUTHOR), Vanella, V.12 (AUTHOR), Gerard, C.L.13 (AUTHOR), Aspeslagh, S.14 (AUTHOR), Labianca, A.15 (AUTHOR), Khattak, A.16 (AUTHOR), Mandala, M.17 (AUTHOR), Xu, W.18 (AUTHOR), Neyns, B.14 (AUTHOR), Michielin, O.13 (AUTHOR)
Source: Annals of Oncology. Jul2021, Vol. 32 Issue 7, p917-925. 9p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2021.03.204